Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?

Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?

Bibliographic Details
Main Authors:	Kim, Seung Tae, Chang, Won Jin, Jin, Lihua, Sung, Jae Sook, Choi, Yun Ji, Kim, Yeul Hong
Format:	Online
Language:	English
Published:	Korean Cancer Association 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614179/

Similar Items

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
by: Kim, Mi-Jung, et al.
Published: (2012)

Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy
by: Kim, Seung Tae, et al.
Published: (2013)

Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?
by: Kim, Seung Tae, et al.
Published: (2014)

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
by: Daeyoun David Won, et al.
Published: (2017-06-01)

The role of kras mutations and MSI status in diagnosis of colorectal cancer
by: Shemirani, Atena Irani, et al.
Published: (2011)

Association between KRAS mutation and lung metastasis in advanced colorectal cancer
by: Pereira, A A L, et al.
Published: (2015)

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
by: Arrington, Amanda K., et al.
Published: (2012)

BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis
by: Nam, Soo Kyung, et al.
Published: (2016)

BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients
by: Chen, Jing, et al.
Published: (2014)

Personalized treatment for advanced colorectal cancer: KRAS and beyond
by: Patel, Gargi Surendra, et al.
Published: (2013)

Impact of KRAS Mutations on Management of Colorectal Carcinoma
by: Sullivan, Kevin M., et al.
Published: (2011)

Novel KRAS Gene Mutations in Sporadic Colorectal Cancer
by: Naser, Walid M., et al.
Published: (2014)

Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients
by: Mekenkamp, Leonie JM, et al.
Published: (2012)

The prognostic role of serum C-X-C chemokine receptor type 4 in patients with metastatic or recurrent colorectal cancer
by: Choi, Yoon Ji, et al.
Published: (2016)

Heterogeneity of KRAS Mutation Status in Rectal Cancer
by: Jo, Peter, et al.
Published: (2016)

p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
by: Kim, Se Hyun, et al.
Published: (2016)

MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers
by: Choi, Yong Won, et al.
Published: (2016)

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: a retrospective analysis
by: Kim, Hae Su, et al.
Published: (2016)

Intra-tumoral Heterogeneity of KRAS and BRAF Mutation Status in Patients with Advanced Colorectal Cancer (aCRC) and Cost-Effectiveness of Multiple Sample Testing
by: Richman, Susan D., et al.
Published: (2011)

KRAS mutational status analysis of peripheral blood isolated circulating tumor cells in metastatic colorectal patients
by: GUTIÉRREZ, CRISTINA, et al.
Published: (2013)

KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers
by: Phipps, A I, et al.
Published: (2013)

Associations of Anthropometric Factors with KRAS and BRAF Mutation Status of Primary Colorectal Cancer in Men and Women: A Cohort Study
by: Brändstedt, Jenny, et al.
Published: (2014)

Molecular Profiling in Resectable Colorectal Liver Metastases: The Role of KRAS Mutation Status in Assessing Prognosis in the Preoperative Setting
by: Coulson, Ryanne
Published: (2015)

EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells
by: Roda, Desamparados, et al.
Published: (2015)

Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations
by: Li, Wenbin, et al.
Published: (2015)

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
by: Yokota, Tomoya
Published: (2012)

Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma
by: Stefanius, Karoliina, et al.
Published: (2011)

Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer
by: Popovici, Vlad, et al.
Published: (2013)

KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
by: Bar, Julia K, et al.
Published: (2012)

KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary
by: Vauthey, J-N, et al.
Published: (2012)

Reply: KRAS mutation in colorectal cancer metastases after adjuvant folfox for the primary
by: Yoshino, T, et al.
Published: (2012)

Characterization of rare transforming KRAS mutations in sporadic colorectal cancer
by: Tong, Joanna HM, et al.
Published: (2014)

Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer
by: Zocche, David M., et al.
Published: (2015)

Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations
by: Li, Wenbin, et al.
Published: (2015)

KRAS mutation in lung metastases from colorectal cancer: prognostic implications
by: Ghidini, Michele, et al.
Published: (2015)

Prognostic significance of KRAS gene mutations in colorectal cancer - preliminary study
by: Dinu, D, et al.
Published: (2014)

Differential Reprogramming of Isogenic Colorectal Cancer Cells by Distinct Activating KRAS Mutations
by: Hammond, Dean E., et al.
Published: (2015)

KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma
by: PALIOGIANNIS, PANAGIOTIS, et al.
Published: (2014)

Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
by: Palomba, Grazia, et al.
Published: (2016)

Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages
by: Li, Wenbin, et al.
Published: (2015)